Collaboration kick-starts at NEURONET first Scientific Coordination Board

 

The ADAPTED project's scientific leader, Margot Bakker of AbbVie Deutschland, attended the first NEURONET Scientific Coordination Board on Tuesday 2nd July in Madrid, Spain. 

 

The meeting brought together the scientific leadership of the Innovative Medicine Initiative's (IMI) Neurodegeneration (ND) portfolio with the goal of kick-starting a collaboration to identify strategies, synergies and to improve the impact of the groundbreaking work being done by projects in fields such as Alzheimer's disease research and Parkinson's disease research. 

 

Margot represented ADAPTED, highlighting that the project can offer its extremely high quality data sets to increase synergies between different ND projects which could potentially facilitate future breakthroughs in Alzheimer's disease research.  

 

NEURONET is an IMI funded project which aims to establish a platform to enable collaboration across the IMI ND portfolio by assisting in identifying gaps, multiplying the portfolio’s impact, and enhancing its visibility with related initiatives in Europe and worldwide.

 

You can stay up to date with ADAPTED and NEURONET collaboration by following on Twitter below!

 

Follow: @adapted_project                                           Follow: @IMI2_NEURONET

 

 

  

Please reload

Other Items
Please reload

©2018 ADAPTED

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115975. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations